Columbus startup awarded $2M in Third Frontier opioid challenge

Story excerpt provided by Columbus Business First.
Written by Carrie Ghose.

Ohio Third Frontier awarded $2 million from an opioid-fighting program to a Columbus company formed in part with previous Third Frontier grants.

Sollis Therapeutics Inc. did not get the full $5 million it sought as the Third Frontier Commission voted Thursday to grant a combined $10 million to seven technologies for preventing or mitigating opioid abuse that demonstrated they’re getting close to market. No other Central Ohio applicants received grants, the largest of which is $3 million.

The grants come from $20 million of the state bond program that Gov. John Kasich set aside to bring forth products and technology to combat the epidemic. There’s still $2 million left toward proven technologies with the best commercialization potential; another $8 million is for a contest open to the public to generate ideas for potential technology.

Click here to read the complete article.
Originally published December 8, 2017.